Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs. (2019)

First Author: Holmes EAF
Attributed to:  MRC North West Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1231

PubMed Identifier: 30204252

Publication URI: http://europepmc.org/abstract/MED/30204252

Type: Journal Article/Review

Volume: 105

Parent Publication: Clinical pharmacology and therapeutics

Issue: 3

ISSN: 0009-9236